Kintara Therapeutics, Inc. (KTRA)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Feb 07, 2025

$4.27

P/E Ratio

N/A

Market Cap

$6.75M

Description
Add to research

Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.

Metrics
Add to research

Overview

  • HQSan Diego, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerKTRA
  • Price$4.27-4.26%

Trading Information

  • Market cap$6.75M
  • Float56.50%
  • Average Daily Volume (1m)194,121
  • Average Daily Volume (3m)342,210
  • EPS-$11.29

Company

  • RevenueN/A
  • Rev growth (1yr)N/A
  • Net income-$8.32M
  • Gross marginN/A
  • EBITDA marginN/A
  • EBITDA-$8.40M
  • EV$12.46M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/BN/A
  • Debt/EquityN/A
Documents
Add to research